The post cites new studies suggesting an unapproved drug bought on the black market doesn't deliver on its promise, on top of the safety risks.
Recap by typeshit. Post by Facebook on Facebook.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
A pharmacist account flags two separate Class II recalls involving compounded tirzepatide. Tap through for which products are affected and why.
Health authorities in New South Wales issued a warning after a jump in hospitalisations linked to unapproved peptides sold as wellness products.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
Researchers at the American Academy of Ophthalmology meeting found NAION patients on GLP-1 drugs tended to develop it in the other eye sooner.
Part of his GLP-1 series, Dr. Krittanawong looks at whether these medications could help protect the heart after a heart attack.
Loading…